NRC Health
NRC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0000070487
No open-market purchases or sales by NRC Health insiders were filed in the last 90 days; 123 institutions reported holding it in 13F filings for Q2 2026, worth $231.9M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in NRC Health as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 110
- −4 vs. Q1 2022
- Shares held
- 11.5M
- +22.1K (+0.2%) vs. Q1 2022
- Total value
- $441.0M
- −$14.7M (−3.2%) vs. Q1 2022
- New holders
- 5
- 45 more added
- Sold out
- 9
- 38 more reduced
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 123 | $231.9M |
| Q1 2026 | 121 | $184.2M |
| Q4 2025 | 117 | $201.6M |
| Q3 2025 | 119 | $142.0M |
| Q2 2025 | 126 | $196.1M |
| Q1 2025 | 123 | $147.3M |
| Q4 2024 | 133 | $209.6M |
| Q3 2024 | 138 | $273.5M |
| Q2 2024 | 136 | $280.3M |
| Q1 2024 | 142 | $505.2M |
| Q4 2023 | 132 | $476.7M |
| Q3 2023 | 121 | $538.4M |
| Q2 2023 | 116 | $507.8M |
| Q1 2023 | 125 | $498.7M |
| Q4 2022 | 116 | $437.3M |
| Q3 2022 | 111 | $464.7M |
| Q2 2022 | 110 | $441.0M |
| Q1 2022 | 116 | $456.3M |
| Q4 2021 | 113 | $473.7M |
| Q3 2021 | 109 | $473.7M |
| Q2 2021 | 101 | $514.2M |
| Q1 2021 | 99 | $511.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding NRC Health; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 291,231 | $11.1M | 0.00% | +25,463+9.6% | Added |
| State Street Corp | 296,673 | $11.4M | 0.00% | −12,073−3.9% | Reduced |
| Renaissance Technologies LLC | 427,784 | $16.4M | 0.02% | −4,200−1.0% | Reduced |
| QV Investors Inc. | 463,280 | $17.7M | 1.61% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 627,987 | $24.0M | 0.01% | +1,153+0.2% | Added |
| Conestoga Capital Advisors, LLC | 731,135 | $28.0M | 0.51% | +2,838+0.4% | Added |
| Atlanta Capital Management Co L L C | 786,967 | $30.1M | 0.13% | −31,485−3.8% | Reduced |
| Vanguard Group Inc | 844,759 | $32.3M | 0.00% | −2,275−0.3% | Reduced |
| BlackRock Inc. | 959,530 | $36.7M | 0.00% | +37,930+4.1% | Added |
| Kayne Anderson Rudnick Investment Management LLC | 3,246,644 | $124.3M | 0.39% | −53,895−1.6% | Reduced |
| Millennium Management LLC | 0 | $0 | 0.00% | −39,375−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −20,357−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −11,041−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −7,800−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −5,329−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −199−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −104−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |